OncoTartis Inc., the U.S. daughter company of Skolkovo resident biomed startup OncoTartis , has raised $6 million in investment to develop its treatment for acute myeloid leukaemia. The acute myeloid leukaemia drug is being developed simultaneously in...
Advanced Gene & Cell Technologies (AGCT) , a resident startup of the Skolkovo Foundation’s biomed cluster, has received the first tranche of investment from the RBV Capital venture fund allocated to carry out Russia’s first clinical practice...
A company working on creating food for prawns from algae has been awarded five million rubles ($82,000) by the Skolkovo Foundation, making it the first startup working in agriculture to receive a mini-grant from the foundation. The company, Solixant , plans...
Морская энергетика может решить проблемы электроснабжения нефте-газодобывающих платформ без воздействия на окружающую среду с помощью новых подводных безопасных для биосферы вихревых гидроэлектростанций. Описание проблемы Наступила новая эра освоения океана...